Role of angiotensin II type 2 receptor during regression of cardiac hypertrophy in spontaneously hypertensive rats

Journal of the American Society of Hypertension

Volumn 7, Issue 2, 2013, Pages 118-127

  Der Sarkissian, Shant ^a   Tea, Bun Seng ^a   Touyz, Rhian M ^b   Deblois, Denis ^a   Hale, Taben M ^a,c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

ACE inhibitor; apoptosis; AT1 antagonist; fibroblast

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ENALAPRIL; PLACEBO; VALSARTAN;

ANGIOTENSIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLEEDING; BLOOD PRESSURE; CONTROLLED STUDY; DNA CONTENT; DNA FRAGMENTATION; DNA SYNTHESIS; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CAPILLARY; HEART MUSCLE CELL; MALE; MESOTHELIUM CELL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR BLOCKING; REMISSION; SPONTANEOUSLY HYPERTENSIVE RAT; STUDY; TREATMENT DURATION;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; CARDIOMEGALY; DNA FRAGMENTATION; ENALAPRIL; IMIDAZOLES; IN SITU NICK-END LABELING; MALE; PHOTOMICROGRAPHY; PYRIDINES; RANDOM ALLOCATION; RATS; RATS, INBRED SHR; RECEPTOR, ANGIOTENSIN, TYPE 2; TETRAZOLES; VALINE;

EID: 84875367675     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2013.01.002     Document Type: Article

References (50)

1. D. Levy, R.J. Garrison, D.D. Savage, W.B. Kannel, and W.P. Castelli Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study N Engl J Med 322 1990 1561 1566
2. S. Der Sarkissian, E.L. Marchand, D. Duguay, P. Hamet, and D. deBlois Reversal of interstitial fibroblast hyperplasia via apoptosis in hypertensive rat heart with valsartan or enalapril Cardiovasc Res 57 2003 775 783
3. B.S. Tea, S. Der Sarkissian, R.M. Touyz, P. Hamet, and D. deBlois Proapoptotic and growth-inhibitory role of angiotensin II type 2 receptor in vascular smooth muscle cells of spontaneously hypertensive rats in vivo Hypertension 35 2000 1069 1073
4. A. Akashiba, H. Ono, Y. Ono, T. Ishimitsu, and H. Matsuoka Valsartan improves L-NAME-exacerbated cardiac fibrosis with TGF-beta inhibition and apoptosis induction in spontaneously hypertensive rats J Cardiol 52 2008 239 246
5. B.S. Tea, T.V. Dam, P. Moreau, P. Hamet, and D. deBlois Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats. Temporal regulation and spatial heterogeneity Hypertension 34 1999 229 235
6. K.E. Bernstein, and R.W. Alexander Counterpoint: molecular analysis of the angiotensin II receptor Endocr Rev 13 1992 381 386
7. H.R. Brunner, Y. Christen, A. Munafo, R.J. Lee, B. Waeber, and J. Nussberger Clinical experience with angiotensin II receptor antagonists Am J Hypertens 5 1992 243S 246S
8. E. Kaschina, A. Grzesiak, J. Li, A. Foryst-Ludwig, M. Timm, and F. Rompe Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction? Circulation 118 2008 2523 2532
9. A. Rehman, A. Leibowitz, N. Yamamoto, Y. Rautureau, P. Paradis, and E.L. Schiffrin Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats Hypertension 59 2012 291 299
10. R.E. Widdop, E.S. Jones, R.E. Hannan, and T.A. Gaspari Angiotensin AT2 receptors: cardiovascular hope or hype? Br J Pharmacol 140 2003 809 824
11. T.L. Reudelhuber The continuing saga of the AT2 receptor: a case of the good, the bad, and the innocuous Hypertension 46 2005 1261 1262
12. U.M. Steckelings, M. Larhed, A. Hallberg, R.E. Widdop, E.S. Jones, and C. Wallinder Non-peptide AT2-receptor agonists Curr Opin Pharmacol 11 2011 187 192
13. T. Yamada, M. Horiuchi, and V.J. Dzau Angiotensin II type 2 receptor mediates programmed cell death Proc Natl Acad Sci U S A 93 1996 156 160
14. D. deBlois, B.S. Tea, V.D. Than, J. Tremblay, and P. Hamet Smooth muscle apoptosis during vascular regression in spontaneously hypertensive rats Hypertension 29 1997 340 349
15. P. Anversa, X. Zhang, P. Li, and J.M. Capasso Chronic coronary artery constriction leads to moderate myocyte loss and left ventricular dysfunction and failure in rats J Clin Invest 89 1992 618 629
16. S. Kurisu, R. Ozono, T. Oshima, M. Kambe, T. Ishida, and H. Sugino Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis Hypertension 41 2003 99 107
17. R.D. Brown, S.K. Ambler, M.D. Mitchell, and C.S. Long The cardiac fibroblast: therapeutic target in myocardial remodeling and failure Annu Rev Pharmacol Toxicol 45 2005 657 687
18. X.Y. Jiang, G.D. Gao, X.J. Du, J. Zhou, X.F. Wang, and Y.X. Lin The signalling of AT2 and the influence on the collagen metabolism of AT2 receptor in adult rat cardiac fibroblasts Acta Cardiol 62 2007 429 438
19. N. Ohkubo, H. Matsubara, Y. Nozawa, Y. Mori, S. Murasawa, and K. Kijima Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism Circulation 96 1997 3954 3962
20. L.B. Stacy, Q. Yu, K. Horak, and D.F. Larson Effect of angiotensin II on primary cardiac fibroblast matrix metalloproteinase activities Perfusion 22 2007 51 55
21. Y. Oishi, R. Ozono, Y. Yano, Y. Teranishi, M. Akishita, and M. Horiuchi Cardioprotective role of AT2 receptor in postinfarction left ventricular remodeling Hypertension 41 2003 814 818
22. Y. Adachi, Y. Saito, I. Kishimoto, M. Harada, K. Kuwahara, and N. Takahashi Angiotensin II type 2 receptor deficiency exacerbates heart failure and reduces survival after acute myocardial infarction in mice Circulation 107 2003 2406 2408
23. B.I. Jugdutt, and V. Menon AT1 receptor blockade limits myocardial injury and upregulates AT2 receptors during reperfused myocardial infarction Mol Cell Biochem 260 2004 111 118
24. B. Zhou, L.B. Honor, H. He, Q. Ma, J.H. Oh, and C. Butterfield Adult mouse epicardium modulates myocardial injury by secreting paracrine factors J Clin Invest 121 2011 1894 1904
25. J.L. Russell, S.C. Goetsch, N.R. Gaiano, J.A. Hill, E.N. Olson, and J.W. Schneider A dynamic notch injury response activates epicardium and contributes to fibrosis repair Circ Res 108 2011 51 59
26. M. Kuwahara, and M. Kuwahara Pericardial mesothelial cells produce endothelin-1 and possess functional endothelin ETB receptors Eur J Pharmacol 347 1998 329 335
27. R. Ou, Y. Sun, V.K. Ganjam, and K.T. Weber In situ production of angiotensin II by fibrosed rat pericardium J Mol Cell Cardiol 28 1996 1319 1327
28. A.C. Gittenberger-de Groot, M.P. Vrancken Peeters, M.M. Mentink, R.G. Gourdie, and R.E. Poelmann Epicardium-derived cells contribute a novel population to the myocardial wall and the atrioventricular cushions Circ Res 82 1998 1043 1052
29. T. Mikawa, and R.G. Gourdie Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with ingrowth of the epicardial organ Dev Biol 174 1996 221 232
30. M.P. Vrancken Peeters, A.C. Gittenberger-de Groot, M.M. Mentink, and R.E. Poelmann Smooth muscle cells and fibroblasts of the coronary arteries derive from epithelial-mesenchymal transformation of the epicardium Anat Embryol (Berl) 199 1999 367 378
31. J.A. Loging, R.B. New, S.C. Baicu, M.K. King, J.W. Hendrick, and F.A. Crawford Jr. Effects of angiotensin type-I receptor blockade on pericardial fibrosis J Surg Res 87 1999 101 107
32. S. Ichihara, T. Senbonmatsu, E. Price Jr., T. Ichiki, F.A. Gaffney, and T. Inagami Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension Circulation 104 2001 346 351
33. T. Senbonmatsu, S. Ichihara, E. Price Jr., F.A. Gaffney, and T. Inagami Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload J Clin Invest 106 2000 R25 R29
34. M. Akishita, M. Iwai, L. Wu, L. Zhang, Y. Ouchi, and V.J. Dzau Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice Circulation 102 2000 1684 1689
35. B.L. Metcalfe, M.J. Huentelman, L.D. Parilak, D.G. Taylor, M.J. Katovich, and H.J. Knot Prevention of cardiac hypertrophy by angiotensin II type-2 receptor gene transfer Hypertension 43 2004 1233 1238
36. X. Yan, A.J. Schuldt, R.L. Price, I. Amende, F.F. Liu, and K. Okoshi Pressure overload-induced hypertrophy in transgenic mice selectively overexpressing AT2 receptors in ventricular myocytes Am J Physiol Heart Circ Physiol 294 2008 H1274 H1281
37. U.M. Steckelings, R.E. Widdop, L. Paulis, and T. Unger The angiotensin AT2 receptor in left ventricular hypertrophy J Hypertens 28 Suppl 1 2010 S50 S55
38. K. Yayama, and H. Okamoto Angiotensin II-induced vasodilation via type 2 receptor: role of bradykinin and nitric oxide Int Immunopharmacol 8 2008 312 318
39. J. Zou, J.H. Ren, D. Feng, H. Wang, and J. Xu Compensatory function of bradykinin B1 receptor in the inhibitory effect of captopril on cardiomyocyte hypertrophy and cardiac fibroblast proliferation in neonatal rats Chin Med J (Engl) 121 2008 1220 1225
40. M. Fujii, A. Wada, M. Ohnishi, T. Tsutamoto, T. Matsumoto, and T. Yamamoto Endogenous bradykinin suppresses myocardial fibrosis through the cardiac-generated endothelin system under chronic angiotensin-converting enzyme inhibition in heart failure J Cardiovasc Pharmacol 44 Suppl 1 2004 S346 S349
41. Y.C. Zhu, Y.Z. Zhu, P. Gohlke, H.M. Stauss, and T. Unger Effects of angiotensin-converting enzyme inhibition and angiotensin II AT1 receptor antagonism on cardiac parameters in left ventricular hypertrophy Am J Cardiol 80 1997 110A 117A
42. P. Gohlke, W. Linz, B. Scholkens, E. Van, P. Martorana, and T. Unger Vascular and cardiac protection by ramipril in spontaneously hypertensive rats: prevention versus regression study Br J Clin Pract Suppl 84 1996 1 10
43. H. Ohashi, H. Takagi, H. Oh, K. Suzuma, I. Suzuma, and N. Miyamoto Phosphatidylinositol 3-kinase/Akt regulates angiotensin II-induced inhibition of apoptosis in microvascular endothelial cells by governing survivin expression and suppression of caspase-3 activity Circ Res 94 2004 785 793
44. B. Tian, J. Liu, P. Bitterman, and R.J. Bache Angiotensin II modulates nitric oxide-induced cardiac fibroblast apoptosis by activation of AKT/PKB Am J Physiol Heart Circ Physiol 285 2003 H1105 H1112
45. B. Tian, J. Liu, P.B. Bitterman, and R.J. Bache Mechanisms of cytokine induced NO-mediated cardiac fibroblast apoptosis Am J Physiol Heart Circ Physiol 283 2002 H1958 H1967
46. E.L. Marchand, S.S. Der, P. Hamet, and D. deBlois Caspase-dependent cell death mediates the early phase of aortic hypertrophy regression in losartan-treated spontaneously hypertensive rats Circ Res 92 2003 777 784
47. Y.H. Lee, O. Mungunsukh, R.L. Tutino, A.P. Marquez, and R.M. Day Angiotensin-II-induced apoptosis requires regulation of nucleolin and Bcl-xL by SHP-2 in primary lung endothelial cells J Cell Sci 123 2010 1634 1643
48. L. Sun, W. Wang, W. Xiao, H. Liang, Y. Yang, and H. Yang Angiotensin II induces apoptosis in intestinal epithelial cells through the AT2 receptor, GATA-6 and the Bax pathway Biochem Biophys Res Commun 424 2012 663 668
49. J.J. Lopez, B.H. Lorell, J.R. Ingelfinger, E.O. Weinberg, H. Schunkert, and D. Diamant Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts Am J Physiol 267 1994 H844 H852
50. G.W. Booz, and K.M. Baker Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy Hypertension 28 1996 635 640